Macrolide-resistant mycoplasma pneumoniae pneumonia in adolescents and adults: Clinical findings, drug susceptibility, and therapeutic efficacy

65Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P=0.0361 and P=0.0237, respectively). Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Miyashita, N., Akaike, H., Teranishi, H., Ouchi, K., & Okimoto, N. (2013). Macrolide-resistant mycoplasma pneumoniae pneumonia in adolescents and adults: Clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrobial Agents and Chemotherapy, 57(10), 5181–5185. https://doi.org/10.1128/AAC.00737-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free